NYSE: AGE - AgeX Therapeutics, Inc.

半年間の収益性: 0%
セクタ: Healthcare

プロモーションスケジュール AgeX Therapeutics, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease.

さらに詳しく
Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Выручка 0.0017
EBITDA -0.0116
Число акций ао 0.001079 млрд
P/S 1.17
P/BV 0.7694
EV/EBITDA -0.1393
Цена ао 11.1
ISIN US00848H1086
Сайт https://www.agexinc.com
Валюта usd
IPO date 2018-11-29
Sector Health Care
Industry Biotechnology
Валюта отчета usd
1日あたりの価格変動: 0% (11.1)
週ごとの価格変動: 0% (11.1)
月ごとの料金変更: 0% (11.1)
3ヶ月間の価格変動: 0% (11.1)
半年間の価格変動: 0% (11.1)
年間の価格変動: +1 494.83% (0.696)
3年間の価格推移: +1 068.42% (0.95)
5年間の価格推移: +323.66% (2.62)
年初からの価格変動: +1 857.67% (0.567)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 2.98 6
P/BV 0.079 10
P/E 0 0
EV/EBITDA -0.4521 0
合計: 5.13

効率

名前 意味 学年
ROA, % -123.72 0
ROE, % -270.67 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.4441 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -91.65 0
収益性 Ebitda, % -15.27 0
収益性 EPS, % 4028.55 10
合計: 2.6
さらに詳しく

機関 音量 共有, %
Broadwood Capital, Inc. 2997156 7.9
Vanguard Group Inc 701755 1.85
Sigma Planning Corp 286425 0.75
Prescott General Partners LLC 185185 0.49
Bridgeway Capital Management, Inc. 144770 0.38
Geode Capital Management, LLC 140994 0.37
Blackrock Inc. 124301 0.33
Strategic Wealth Investment Group, LLC 97375 0.26
Creative Planning 70700 0.19
Northern Trust Corporation 31533 0.08

ETF 共有, % 年間の利益率, % 配当金, %
Global X Uranium ETF 0.21695 7.8444984380424 1.74266
Sprott Uranium Miners ETF 0.42828 343.51683999618 3.27507



スーパーバイザー 役職 支払い 生年
Ms. Eun-Jae Park CPA Chief Financial Officer 295.29k 1972 (52 年)
Dr. Ivan Labat Chief Information Officer N/A
Ms. Judith Segall Secretary N/A 1953 (71 年)

住所: United States, Alameda. CA, 1101 Marina Village Parkway - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.agexinc.com